The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kleiger, R. E., Miller, J. P., Bigger, J. T., & Moss, A. J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90795-8 · Cited by 3,995
Nolan, J., Batin, P. D., Andrews, R., Lindsay, S. J., Brooksby, P., Mullen, M., Baig, W., Flapan, A. D., Cowley, A., Prescott, R. J., et al. (1998) · Circulation · doi:10.1161/01.cir.98.15.1510 · Cited by 1,179
Research works printed but not linked: 18
- Waagstein, 1975, Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy, Br Heart J, 37, 1022, 10.1136/hrt.37.10.1022 · DOI
- 1998, 3-year follow-up of patients randomised in the Metoprolol in Dilated Cardiomyopathy Trial, Lancet, 351, 1180, 10.1016/S0140-6736(05)79125-X · DOI
- 1997, Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease, Lancet, 349, 375, 10.1016/S0140-6736(97)80008-6 · DOI
- Doughty, 1997, Effects of beta-blocker therapy on mortality in patients with heart failure: a systematic overview of randomised controlled trials, Eur Heart J, 8, 560, 10.1093/oxfordjournals.eurheartj.a015297 · DOI
- Heidenrich, 1997, Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials, J Am Coll Cardiol, 30, 27, 10.1016/S0735-1097(97)00104-6 · DOI
- Lechat, 1998, Beta-blockers in heart failure: meta-analysis of randomized trials, Circulation, 98, 1184, 10.1161/01.CIR.98.12.1184 · DOI
- Haeusler, 1986, High β1 selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol, J Cardiovasc Pharmacol, 8, S2
- 1994, A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS), Circulation, 90, 765
- 1997, Design of the Cardiac Insufficiency Bisoprolol Study II (CIBIS II), Fund Clin Pharmacol, 11, 38
- Peto, 1976, Design and analysis of randomised clinical trials requiring prolonged observation of each patient, I: introduction and design, Br J Cancer, 34, 585, 10.1038/bjc.1976.220 · DOI · Paper page
- Garg, 1995, Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure, JAMA, 273, 1450, 10.1001/jama.1995.03520420066040 · DOI · Paper page
- Gottlieb, 1998, Effect of beta-blockade on mortality among high risk and low risk patients after myocardial infarction, N Engl J Med, 339, 489, 10.1056/NEJM199808203390801 · DOI
- Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 · DOI · Paper page
- Pousset, 1996, Effects of bisoprolol on heart rate variability in heart failure, Am J Cardiol, 77, 612, 10.1016/S0002-9149(97)89316-2 · DOI
- Copie, 1996, Effects of beta-blockade with bisoprolol on heart rate variability in advanced heart failure: analysis of scatterplots of RR intervals at selected heart rates, Am Heart J, 132, 369, 10.1016/S0002-8703(96)90435-4 · DOI
- Bristow, 1996, Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure, Circulation, 4, 2807, 10.1161/01.CIR.94.11.2807 · DOI · Paper page
- Lechat, 1997, Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study, Circulation, 96, 2197, 10.1161/01.CIR.96.7.2197 · DOI
- 1995, Design of the Beta-blocker Evaluation Survival Trial, Am J Cardiol, 5, 1220
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Metadata
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 353
- Issue
- 9146
- Pages
- 9-13
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2296998040
- Cited by
- 4,929
- References
- 2
- FWCI
- 214.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. https://app.cochat.ai/papers/10.1016/s0140-6736(98)11181-9
- The paper
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. (1999). The Lancet. https://doi.org/10.1016/s0140-6736(98)11181-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
